AAAAAA
Results:
1-12
|
Results: 12
Authors:
LEUTENEGGER CM
HOFMANNLEHMANN R
HOLZNAGEL E
CUISINIER AM
WOLFENSBERGER C
DUQUESNE V
CRONIER J
ALLENSPACH K
AUBERT A
OSSENT P
LUTZ H
Citation: Cm. Leutenegger et al., PARTIAL PROTECTION BY VACCINATION WITH RECOMBINANT FELINE IMMUNODEFICIENCY VIRUS SURFACE GLYCOPROTEINS, AIDS research and human retroviruses, 14(3), 1998, pp. 275-283
Authors:
HOFMANNLEHMANN R
HOLZNAGEL E
LUTZ H
Citation: R. Hofmannlehmann et al., FEMALE CATS HAVE LOWER RATES OF APOPTOSIS IN PERIPHERAL-BLOOD LYMPHOCYTES THAN MALE CATS - CORRELATION WITH ESTRADIOL-17-BETA, BUT NOT WITHPROGESTERONE BLOOD-LEVELS, Veterinary immunology and immunopathology, 65(2-4), 1998, pp. 151-160
Authors:
HOLZNAGEL E
HOFMANNLEHMANN R
LEUTENEGGER CM
ALLENSPACH K
HUETTNER S
FORSTER U
NIEDERER E
JOLLER H
WILLETT BJ
HUMMEL U
ROSSI GL
SCHUPBACH J
LUTZ H
Citation: E. Holznagel et al., THE ROLE OF IN VITRO-INDUCED LYMPHOCYTE APOPTOSIS IN FELINE IMMUNODEFICIENCY VIRUS-INFECTION - CORRELATION WITH DIFFERENT MARKERS OF DISEASE PROGRESSION, Journal of virology (Print), 72(11), 1998, pp. 9025-9033
Authors:
HOFMANNLEHMANN R
HOLZNAGEL E
OSSENT P
LUTZ H
Citation: R. Hofmannlehmann et al., PARAMETERS OF DISEASE PROGRESSION IN LONG-TERM EXPERIMENTAL FELINE RETROVIRUS (FELINE IMMUNODEFICIENCY VIRUS AND FELINE LEUKEMIA-VIRUS) INFECTIONS - HEMATOLOGY, CLINICAL-CHEMISTRY, AND LYMPHOCYTE SUBSETS, Clinical and diagnostic laboratory immunology, 4(1), 1997, pp. 33-42
Authors:
FEHR D
HOLZNAGEL E
BOLLA S
HAUSER B
HERREWEGH AAPM
HORZINEK MC
LUTZ H
Citation: D. Fehr et al., PLACEBO-CONTROLLED EVALUATION OF A MODIFIED LIFE VIRUS-VACCINE AGAINST FELINE INFECTIOUS PERITONITIS - SAFETY AND EFFICACY UNDER FIELD CONDITIONS, Vaccine, 15(10), 1997, pp. 1101-1109
Authors:
AKENS MK
HOLZNAGEL E
FRANCHINI M
BRACHER V
Citation: Mk. Akens et al., COMPARATIVE-ANALYSIS OF EQUINE LYMPHOCYTE SUBSETS IN WHOLE-BLOOD AND GRADIENT-PURIFIED SAMPLES, Veterinary immunology and immunopathology, 58(3-4), 1997, pp. 231-237
Authors:
HOLZNAGEL E
LUTZ H
STEINHAUER D
REINACHER M
Citation: E. Holznagel et al., FELINE IMMUNODEFICIENCY VIRUS (FIV) INFECTION IN CATS AT NECROPSY - ASEROLOGICAL STUDY, Journal of Comparative Pathology, 116(4), 1997, pp. 339-352
Authors:
HOLZNAGEL E
HOFMANNLEHMANN R
ALLENSPACH K
HUTTNER S
WILLETT B
GROSCURTH P
NIEDERER E
LUTZ H
Citation: E. Holznagel et al., FLOW CYTOMETRIC DETECTION OF ACTIVATION-INDUCED CELL-DEATH (APOPTOSIS) IN PERIPHERAL-BLOOD LYMPHOCYTE SUBPOPULATIONS FROM HEALTHY CATS, Veterinary immunology and immunopathology, 52(1-2), 1996, pp. 1-14
Authors:
FEHR D
HOLZNAGEL E
BOLLA S
HAUSER B
HERREWEGH AAPM
HORZINEK MC
LUTZ H
Citation: D. Fehr et al., EVALUATION OF THE SAFETY AND EFFICACY OF A MODIFIED-LIVE FIPV VACCINEUNDER FIELD CONDITIONS, Feline practice, 23(3), 1995, pp. 83-88
Authors:
LUTZ H
HOFMANNLEHMANN R
BAUERPHAM K
HOLZNAGEL E
TOZZINI F
BENDINELLI M
REUBEL G
AUBERT A
DAVIS D
COX D
YOUNG E
Citation: H. Lutz et al., FIV VACCINE STUDIES .1. IMMUNE-RESPONSE TO RECOMBINANT FIV ENV GENE-PRODUCTS AND OUTCOME AFTER CHALLENGE INFECTION, Veterinary immunology and immunopathology, 46(1-2), 1995, pp. 103-113
Authors:
HOFMANNLEHMANN R
HOLZNAGEL E
AUBERT A
BAUERPHAM K
LUTZ H
Citation: R. Hofmannlehmann et al., FIV VACCINE STUDIES .2. CLINICAL FINDINGS, HEMATOLOGICAL-CHANGES AND KINETICS OF BLOOD LYMPHOCYTE SUBSETS, Veterinary immunology and immunopathology, 46(1-2), 1995, pp. 115-125
Authors:
HOFMANNLEHMANN R
HOLZNAGEL E
AUBERT A
OSSENT P
REINACHER M
LUTZ H
Citation: R. Hofmannlehmann et al., RECOMBINANT FELV VACCINE - LONG-TERM PROTECTION AND EFFECT ON COURSE AND OUTCOME OF FIV INFECTION, Veterinary immunology and immunopathology, 46(1-2), 1995, pp. 127-137
Risultati:
1-12
|